(API) Active Pharmaceutical Ingredients Market Size, Trends and Insights By Synthesis (Synthetic, Biotech), By Manufacturer (Captive, Merchant), By Type (Innovative, Generic), By Application (Oncology, Cardiovascular diseases, Ophthalmology, Orthopedic, Central nervous system and neurology, Gastroenterology, Nephrology, Others), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2022–2030


Report Code: CMI18535

Published Date: September 2022

Pages: 220+

Category: Pharmaceuticals

Report Snapshot

CAGR: 6%
211.23 B
2021
225.44B
2022
355.87 B
2030

Source: CMI

Study Period: 2022-2030
Fastest Growing Market: Asia-Pacific
Largest Market: Europe

Major Players

  • Merck & Co Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Albemarle Corporation
  • Others

Exclusive, in-depth market intelligence can help you increase your Revenue.

Download Sample Pdf

Reports Description

According to Custom Market Insights (CMI), The Global Active Pharmaceutical Ingredients Market Size was valued at USD 211.23 billion in 2021 and is expected to reach USD 225.44 billion in 2022, and is estimated to reach USD 355.87 billion by the end of 2030 at a CAGR of approximately 6 % during the forecast period 2022-2030. 

Active pharmaceutical ingredients are used in manufacturing different types of drugs to have a particular result. The use of these ingredients in manufacturing such drugs is called bulk drugs. Biological processes or chemical processes manufacture these drugs. Due to constant research and development in this field, there have been major advancements and innovations that will lead to market growth during the forecast period. These research and development activities will provide enhanced therapeutic drugs manufactured by biotechnology and pharmaceutical companies in the coming years.

The increasing geriatric population across the globe and the increased cases of chronic disorders will drive market growth in the coming years. the demand for personalized medicines has also grown in recent years period due to the introduction and the emergence of mobile devices that are used in the drug delivery market the active pharmaceutical ingredients market is expected to grow well during the forecast period. Many pharmaceutical industries have set up manufacturing units in different countries to improve their market presence. As different regions have different guidelines for producing any product, there were many changes in manufacturing these drugs.

The policy related to pricing various drugs in developing regions cannot be anticipated. The fluctuation in these prizes will hamper the market’s growth in the coming years. Most of the developed regions across the globe depend on China to procure these active ingredients. When the policy is related to pricing changes in China, it will hamper the market on a large scale. All of these reasons shall hinder the market growth in the coming years.

Due to the outbreak of the COVID-19 pandemic, the growth of the market was hampered. As many companies and factories were closed during the pandemic, especially in a nation like China and India, the market had come down. Disrupted supply chains created a shortage of raw materials, which stopped manufacturing in these factories.

Active Pharmaceutical Ingredients (API) Market (By Type)

To learn more about this report, 

Also, there was a drop in the demand for various pharmaceutical products as many procedures that required these products were postponed due to the outbreak of the COVID-19 pandemic. The demand for active pharmaceutical ingredients has reduced due to various restrictions imposed in different regions. The revenues of the companies had also declined in that year. The market has seen slow growth in recent years.

Growth Factors 

The increasing geriatric population globally has led to an increase in chronic disorders. The rapid increase in these diseases will create a demand for the product in the coming years as most of the population across the globe is leading a sedentary lifestyle due to rapid urbanization and industrialization. These factors will create more demand for the drugs during the forecast period. The Pharmaceutical industry in India is expected to grow well during the forecast period. The Indian market meets nearly 50% of the demand for vaccines in the entire world. Apart from India, the market in China is also expected to grow well.

Increased chronic disorders and increasing cases of other types of diseases will lead to the market’s growth as there will be an increase in different types of drugs in the coming years. Constant research and development have been instrumental in providing better biological and innovative drugs on the market. The market is also expected to grow due to a growing demand for biosimilars and biologics.

In recent years there has been a growth in the imports made of different types of raw materials used to manufacture drugs. In recent years, there has been an increase in cases of infectious diseases across the globe. The demand for active pharmaceutical ingredients will continue to grow as there will be an increase in the number of infections and an increase in chronic disorders. It shall impose a burden on pharmaceutical companies to provide innovative drugs.

Active Pharmaceutical Ingredients (API) Market (By Synthesis)

To learn more about this report, 

As a patient suffering from cancer in the European region are growing on a large scale, the demand for these drugs will continue to grow in the coming years. About 17.9 million have died due to cardiovascular diseases, and the demand for drugs will continue to grow to overcome this. An increase in different types of diseases will provide better opportunities to grow active pharmaceutical ingredients in the coming years.

The biotechnology industries and pharmaceutical industries will engage in the production of different types of drugs to meet the demand of the market. Increased production of drugs used in treating cancer and cardiovascular diseases will be instrumental in driving the market’s growth during the forecast period. As the number of dual-income houses have increased, there has also been an increase in the per capita income in developing nations. Most of these regions can spend more on healthcare services. There has also been a spike in the diagnosis of various diseases in these countries due to the availability of good healthcare systems and the expenditure made by the population.

The active pharmaceutical ingredients market segment is based on the Type of Synthesis

The synthetic segment is expected to grow well in the coming years period this segment has dominated the market in the past with a share of about 73% in revenue. As the raw materials are available on a large scale, the market will continue to grow in the coming years. The biotech segment will also grow well in the coming years as the demand for biopharmaceuticals will grow. Major investments are made in the biopharmaceutical and biotechnology sectors, due to which the market will grow in the coming years.

Active pharmaceutical ingredients market segment based on the Type of Manufacturer

Depending upon the type of manufacturer, the captive active pharmaceutical ingredient segment will grow well during the forecast period. This segment will dominate the market as it has in the past by having a share of about 59% in revenue. The raw materials are available at lower costs, so the market will continue to grow in the coming years. There has been an increase in the investments made by organizations or companies to have better production facilities.

Active pharmaceutical ingredients market segment based on the Type

Based on the Type, the innovative segment is expected to have the largest market share in the coming year. The segment has dominated in the past by holding a share of about 66%. Constant research and development activities in various regions will drive market growth. The rules and regulations laid down by the government of various regions are favorable. Introducing novel drug therapies will also be instrumental in the market’s growth. As many new startups are entering the market, there shall be growth. As the demand for personalized medicines seems to increase, the demand for active ingredients will also grow.

Active pharmaceutical ingredients market segment based on Application

Based on Application, the cardiovascular segment is expected to have the largest market share in the coming years. This segment has dominated the market in the past with a share of about 19% in revenue. Increased cases of cardiovascular diseases in various nations across the globe will drive market growth in the coming years. Many organizations are working on increasing awareness regarding the causes of cardiovascular diseases and the treatments available for the same.

Active Pharmaceutical Ingredients (API) Market (By Manufacturer)

To learn more about this report, 

The government takes many initiatives to create awareness regarding lifestyle-related disorders. Apart from the use of these drugs in curing cardiovascular diseases, they will also be used on a large scale in the oncology segment. This segment is also expected to grow well and will expand with a compound annual growth rate of about 9% in the coming years. Culture across the globe has increased the sedentary lifestyle of the population, which has created problems with the metabolic systems. There have been increased cases of hormonal imbalance, and all of these factors will drive market growth in the coming years.
Report Scope

Feature of the Report Details
Market Size in 2021 USD 211.23 billion
Projected Market Size in 2030 USD 355.87 billion
CAGR Growth Rate 6% CAGR
Base Year 2021
Forecast Period 2022-2030
Prominent Players Merck & Co Inc., Teva Pharmaceutical Industries Ltd., Albemarle Corporation, Viatris Inc., Aurobindo Pharma, Sun Pharmaceutical Industries Ltd., AbbVie Inc., Bristol-Myers Squibb Company, Boehringer Ingelheim International GmbH, Cipla Inc., Dr. Reddy’s Laboratories Ltd., and Others
Key Segment By Synthesis, Manufacture, Type, Application, and Region
Report Coverage Revenue Estimation and Forecast, Company Profile, Competitive Landscape, Growth Factors and Recent Trends
Regional Scope North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America
Buying Options Request tailored purchasing options to fulfil your requirements for research.

Regional Insights

The North American region has dominated the market in the past with a share of about 39% in revenue. This region will dominate the market in the coming years due to various reasons. The increasing prevalence of cancer and other types of diseases that are induced due to the lifestyle of the people in the North American region will drive market growth in the coming years. To treat all these diseases, there has been an increase in the investment made in research and development. Apart from the North American region, the Asia Pacific region is also expected to grow well in the coming years period it is expected to grow at a compound annual growth rate of 7% in the coming years.

Countries like India and China are engaged in producing active pharmaceutical ingredients, and most countries across the globe rely on these nations. Due to the availability of raw materials at a lower cost and labor at a lower cost, the market will continue to grow in the coming years. The expenditure on the healthcare industry of the Asia Pacific region will help grow the market in the coming years. The European region is also expected to see good growth as there has been an increased investment in research and many Active Pharmaceutical Ingredients market players are present in the European region. The biopharmaceutical industry is growing in the European region. The investments made in these industries are also helpful in driving the growth of the market.

Active Pharmaceutical Ingredients (API) Market (trends by region)

To learn more about this report, 

Recent Development

  • Rodeo Therapeutics was acquired by Amgen in 2021, and this acquisition will focus on expanding the active pharmaceutical ingredients portfolio for inflammation.
  • Vanamali organics was acquired by wavelength pharmaceuticals in the year 2021. This acquisition aims at strengthening the supply chain of this organization across the globe.

Segments covered in the report

By Synthesis

  • Synthetic
  • Biotech

By Manufacturer

  • Captive
  • Merchant

By Type

  • Innovative
  • Generic

By Application

  • Oncology
  • Cardiovascular diseases
  • Ophthalmology
  • Orthopedic
  • Central nervous system and neurology
  • Gastro enterology
  • Nephrology
  • Others

On the basis of Geography

North America

  • The U.S.
  • Canada
  • Mexico

Europe

  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific

The Middle East & Africa

  • Saudi Arabia
  • UAE
  • Egypt
  • Kuwait
  • South Africa
  • Rest of the Middle East & Africa

Latin America

  • Brazil
  • Argentina
  • Rest of Latin America

Table of Contents

  • Chapter 1. Preface
    • 1.1 Report Description and Scope
    • 1.2 Research scope
    • 1.3 Research methodology
      • 1.3.1 Market Research Type
      • 1.3.2 Market research methodology
  • Chapter 2. Executive Summary
    • 2.1 Global Active Pharmaceutical Ingredients Market, (2022 – 2030) (USD Billion)
    • 2.2 Global Active Pharmaceutical Ingredients Market: snapshot
  • Chapter 3. Global Active Pharmaceutical Ingredients Market – Industry Analysis
    • 3.1 Active Pharmaceutical Ingredients Market: Market Dynamics
    • 3.2 Market Drivers
      • 3.2.1 Increasing Geriatric Population
      • 3.2.2 Sedentary Lifestyle
      • 3.2.3 Chronic Disorders
    • 3.3 Market Restraints
    • 3.4 Market Opportunities
    • 3.5 Market Challenges
    • 3.6 Porter’s Five Forces Analysis
    • 3.7 Market Attractiveness Analysis
      • 3.7.1 Market attractiveness analysis By Synthesis
      • 3.7.2 Market attractiveness analysis By Manufacturer
      • 3.7.3 Market attractiveness analysis By Type
      • 3.7.4 Market attractiveness analysis By Application
  • Chapter 4. Global Active Pharmaceutical Ingredients Market- Competitive Landscape
    • 4.1 Company market share analysis
      • 4.1.1 Global Active Pharmaceutical Ingredients Market: company market share, 2021
    • 4.2 Strategic development
      • 4.2.1 Acquisitions & mergers
      • 4.2.2 New Product launches
      • 4.2.3 Agreements, partnerships, cullaborations, and joint ventures
      • 4.2.4 Research and development and Regional expansion
    • 4.3 Price trend analysis
  • Chapter 5. Global Active Pharmaceutical Ingredients Market – Synthesis Analysis
    • 5.1 Global Active Pharmaceutical Ingredients Market overview: By Synthesis
      • 5.1.1 Global Active Pharmaceutical Ingredients Market share, By Synthesis, 2021 and 2030
    • 5.2 Synthetic
      • 5.2.1 Global Active Pharmaceutical Ingredients Market by Synthetic, 2022 – 2030 (USD Billion)
    • 5.3 Biotech
      • 5.3.1 Global Active Pharmaceutical Ingredients Market by Biotech, 2022 – 2030 (USD Billion)
  • Chapter 6. Global Active Pharmaceutical Ingredients Market – Manufacturer Analysis
    • 6.1 Global Active Pharmaceutical Ingredients Market overview: By Manufacturer
      • 6.1.1 Global Active Pharmaceutical Ingredients Market share, By Manufacturer, 2021 and 2030
    • 6.2 Merchant
      • 6.2.1 Global Active Pharmaceutical Ingredients Market by Merchant, 2022 – 2030 (USD Billion)
    • 6.3 Captive
      • 6.3.1 Global Active Pharmaceutical Ingredients Market by Captive, 2022 – 2030 (USD Billion)
  • Chapter 7. Global Active Pharmaceutical Ingredients Market – Type Analysis
    • 7.1 Global Active Pharmaceutical Ingredients Market overview: By Type
      • 7.1.1 Global Active Pharmaceutical Ingredients Market share, By Type, 2021 and 2030
    • 7.2 Innovative
      • 7.2.1 Global Active Pharmaceutical Ingredients Market by Innovative, 2022 – 2030 (USD Billion)
    • 7.3 Generic
      • 7.3.1 Global Active Pharmaceutical Ingredients Market by Generic, 2022 – 2030 (USD Billion)
  • Chapter 8. Global Active Pharmaceutical Ingredients Market – Application Analysis
    • 8.1 Global Active Pharmaceutical Ingredients Market overview: By Application
      • 8.1.1 Global Active Pharmaceutical Ingredients Market share, By Application, 2021 and 2030
    • 8.2 Oncology
      • 8.2.1 Global Active Pharmaceutical Ingredients Market by Oncology, 2022 – 2030 (USD Billion)
    • 8.3 Cardiovascular diseases
      • 8.3.1 Global Active Pharmaceutical Ingredients Market by Cardiovascular diseases, 2022 – 2030 (USD Billion)
    • 8.4 Ophthalmology
      • 8.4.1 Global Active Pharmaceutical Ingredients Market by Ophthalmology, 2022 – 2030 (USD Billion)
    • 8.5 Orthopedic
      • 8.5.1 Global Active Pharmaceutical Ingredients Market by Orthopedic, 2022 – 2030 (USD Billion)
    • 8.6 Central nervous system
      • 8.6.1 Global Active Pharmaceutical Ingredients Market by Central nervous system, 2022 – 2030 (USD Billion)
    • 8.7 neurology
      • 8.7.1 Global Active Pharmaceutical Ingredients Market by neurology, 2022 – 2030 (USD Billion)
    • 8.8 Gastro enterology
      • 8.8.1 Global Active Pharmaceutical Ingredients Market by Gastro enterology, 2022 – 2030 (USD Billion)
    • 8.9 Nephrology
      • 8.9.1 Global Active Pharmaceutical Ingredients Market by Nephrology, 2022 – 2030 (USD Billion)
  • Chapter 9. Active Pharmaceutical Ingredients Market – Regional Analysis
    • 9.1 Global Active Pharmaceutical Ingredients Market Regional Overview
    • 9.2 Global Active Pharmaceutical Ingredients Market Share, by Region, 2021 & 2030 (USD Billion)
    • 9.3. North America
      • 9.3.1 North America Active Pharmaceutical Ingredients Market, 2022 – 2030 (USD Billion)
        • 9.3.1.1 North America Active Pharmaceutical Ingredients Market, by Country, 2022 – 2030 (USD Billion)
    • 9.4 North America Active Pharmaceutical Ingredients Market, by Synthesis, 2022 – 2030
      • 9.4.1 North America Active Pharmaceutical Ingredients Market, by Synthesis, 2022 – 2030 (USD Billion)
    • 9.5 North America Active Pharmaceutical Ingredients Market, by Manufacturer, 2022 – 2030
      • 9.5.1 North America Active Pharmaceutical Ingredients Market, by Manufacturer, 2022 – 2030 (USD Billion)
    • 9.6 North America Active Pharmaceutical Ingredients Market, by Type, 2022 – 2030
      • 9.6.1 North America Active Pharmaceutical Ingredients Market, by Type, 2022 – 2030 (USD Billion)
    • 9.7 North America Active Pharmaceutical Ingredients Market, by Application, 2022 – 2030
      • 9.7.1 North America Active Pharmaceutical Ingredients Market, by Application, 2022 – 2030 (USD Billion)
    • 9.8. Europe
      • 9.8.1 Europe Active Pharmaceutical Ingredients Market, 2022 – 2030 (USD Billion)
        • 9.8.1.1 Europe Active Pharmaceutical Ingredients Market, by Country, 2022 – 2030 (USD Billion)
    • 9.9 Europe Active Pharmaceutical Ingredients Market, by Synthesis, 2022 – 2030
      • 9.9.1 Europe Active Pharmaceutical Ingredients Market, by Synthesis, 2022 – 2030 (USD Billion)
    • 9.10 Europe Active Pharmaceutical Ingredients Market, by Manufacturer, 2022 – 2030
      • 9.10.1 Europe Active Pharmaceutical Ingredients Market, by Manufacturer, 2022 – 2030 (USD Billion)
    • 9.11 Europe Active Pharmaceutical Ingredients Market, by Type, 2022 – 2030
      • 9.11.1 Europe Active Pharmaceutical Ingredients Market, by Type, 2022 – 2030 (USD Billion)
    • 9.12 Europe Active Pharmaceutical Ingredients Market, by Application, 2022 – 2030
      • 9.12.1 Europe Active Pharmaceutical Ingredients Market, by Application, 2022 – 2030 (USD Billion)
    • 9.13. Asia Pacific
      • 9.13.1 Asia Pacific Active Pharmaceutical Ingredients Market, 2022 – 2030 (USD Billion)
        • 9.13.1.1 Asia Pacific Active Pharmaceutical Ingredients Market, by Country, 2022 – 2030 (USD Billion)
    • 9.14 Asia Pacific Active Pharmaceutical Ingredients Market, by Synthesis, 2022 – 2030
      • 9.14.1 Asia Pacific Active Pharmaceutical Ingredients Market, by Synthesis, 2022 – 2030 (USD Billion)
    • 9.15 Asia Pacific Active Pharmaceutical Ingredients Market, by Manufacturer, 2022 – 2030
      • 9.15.1 Asia Pacific Active Pharmaceutical Ingredients Market, by Manufacturer, 2022 – 2030 (USD Billion)
    • 9.16 Asia Pacific Active Pharmaceutical Ingredients Market, by Type, 2022 – 2030
      • 9.16.1 Asia Pacific Active Pharmaceutical Ingredients Market, by Type, 2022 – 2030 (USD Billion)
    • 9.17 Asia Pacific Active Pharmaceutical Ingredients Market, by Application, 2022 – 2030
      • 9.17.1 Asia Pacific Active Pharmaceutical Ingredients Market, by Application, 2022 – 2030 (USD Billion)
    • 9.18. Latin America
      • 9.18.1 Latin America Active Pharmaceutical Ingredients Market, 2022 – 2030 (USD Billion)
        • 9.18.1.1 Latin America Active Pharmaceutical Ingredients Market, by Country, 2022 – 2030 (USD Billion)
    • 9.19 Latin America Active Pharmaceutical Ingredients Market, by Synthesis, 2022 – 2030
      • 9.19.1 Latin America Active Pharmaceutical Ingredients Market, by Synthesis, 2022 – 2030 (USD Billion)
    • 9.20 Latin America Active Pharmaceutical Ingredients Market, by Manufacturer, 2022 – 2030
      • 9.20.1 Latin America Active Pharmaceutical Ingredients Market, by Manufacturer, 2022 – 2030 (USD Billion)
    • 9.21 Latin America Active Pharmaceutical Ingredients Market, by Type, 2022 – 2030
      • 9.21.1 Latin America Active Pharmaceutical Ingredients Market, by Type, 2022 – 2030 (USD Billion)
    • 9.22 Latin America Active Pharmaceutical Ingredients Market, by Application, 2022 – 2030
      • 9.22.1 Latin America Active Pharmaceutical Ingredients Market, by Application, 2022 – 2030 (USD Billion)
    • 9.23. The Middle-East and Africa
      • 9.23.1 The Middle-East and Africa Active Pharmaceutical Ingredients Market, 2022 – 2030 (USD Billion)
        • 9.23.1.1 The Middle-East and Africa Active Pharmaceutical Ingredients Market, by Country, 2022 – 2030 (USD Billion)
    • 9.24 The Middle-East and Africa Active Pharmaceutical Ingredients Market, by Synthesis, 2022 – 2030
      • 9.24.1 The Middle-East and Africa Active Pharmaceutical Ingredients Market, by Synthesis, 2022 – 2030 (USD Billion)
    • 9.25 The Middle-East and Africa Active Pharmaceutical Ingredients Market, by Manufacturer, 2022 – 2030
      • 9.25.1 The Middle-East and Africa Active Pharmaceutical Ingredients Market, by Manufacturer, 2022 – 2030 (USD Billion)
    • 9.26 The Middle-East and Africa Active Pharmaceutical Ingredients Market, by Type, 2022 – 2030
      • 9.26.1 The Middle-East and Africa Active Pharmaceutical Ingredients Market, by Type, 2022 – 2030 (USD Billion)
    • 9.27 The Middle-East and Africa Active Pharmaceutical Ingredients Market, by Application, 2022 – 2030
      • 9.27.1 The Middle-East and Africa Active Pharmaceutical Ingredients Market, by Application, 2022 – 2030 (USD Billion)
  • Chapter 10. Company Profiles
    • 10.1 Merck & Co Inc.
      • 10.1.1 Overview
      • 10.1.2 Financials
      • 10.1.3 Product Portfolio
      • 10.1.4 Business Strategy
      • 10.1.5 Recent Developments
    • 10.2 Teva Pharmaceutical Industries Ltd.
      • 10.2.1 Overview
      • 10.2.2 Financials
      • 10.2.3 Product Portfolio
      • 10.2.4 Business Strategy
      • 10.2.5 Recent Developments
    • 10.3 Albemarle Corporation
      • 10.3.1 Overview
      • 10.3.2 Financials
      • 10.3.3 Product Portfolio
      • 10.3.4 Business Strategy
      • 10.3.5 Recent Developments
    • 10.4 Viatris Inc.
      • 10.4.1 Overview
      • 10.4.2 Financials
      • 10.4.3 Product Portfolio
      • 10.4.4 Business Strategy
      • 10.4.5 Recent Developments
    • 10.5 Aurobindo Pharma
      • 10.5.1 Overview
      • 10.5.2 Financials
      • 10.5.3 Product Portfolio
      • 10.5.4 Business Strategy
      • 10.5.5 Recent Developments
    • 10.6 Sun Pharmaceutical Industries Ltd.
      • 10.6.1 Overview
      • 10.6.2 Financials
      • 10.6.3 Product Portfolio
      • 10.6.4 Business Strategy
      • 10.6.5 Recent Developments
    • 10.7 AbbVie Inc.
      • 10.7.1 Overview
      • 10.7.2 Financials
      • 10.7.3 Product Portfolio
      • 10.7.4 Business Strategy
      • 10.7.5 Recent Developments
    • 10.8 Bristol-Myers Squibb Company
      • 10.8.1 Overview
      • 10.8.2 Financials
      • 10.8.3 Product Portfolio
      • 10.8.4 Business Strategy
      • 10.8.5 Recent Developments
    • 10.9 Boehringer Ingelheim International GmbH
      • 10.9.1 Overview
      • 10.9.2 Financials
      • 10.9.3 Product Portfolio
      • 10.9.4 Business Strategy
      • 10.9.5 Recent Developments
    • 10.10 Cipla Inc.
      • 10.10.1 Overview
      • 10.10.2 Financials
      • 10.10.3 Product Portfolio
      • 10.10.4 Business Strategy
      • 10.10.5 Recent Developments
    • 10.11 Dr. Reddy’s Laboratories Ltd.
      • 10.11.1 Overview
      • 10.11.2 Financials
      • 10.11.3 Product Portfolio
      • 10.11.4 Business Strategy
      • 10.11.5 Recent Developments
    • 10.12 and Others
      • 10.12.1 Overview
      • 10.12.2 Financials
      • 10.12.3 Product Portfolio
      • 10.12.4 Business Strategy
      • 10.12.5 Recent Developments

List Of Figures

  • 1. Market research Type
  • 2. Market research methodology
  • 3. Global Active Pharmaceutical Ingredients Market, 2022 – 2030 (USD Billion)
  • 4. Porter’s Five Forces Analysis
  • 5. Global Active Pharmaceutical Ingredients Market attractiveness, By Synthesis
  • 6. Global Active Pharmaceutical Ingredients Market attractiveness, By Manufacturer
  • 7. Global Active Pharmaceutical Ingredients Market attractiveness, By Type
  • 8. Global Active Pharmaceutical Ingredients Market attractiveness, By Application
  • 9. Global Active Pharmaceutical Ingredients Market share by Synthesis, 2022 and 2030 (USD Billion)
  • 10. Global Active Pharmaceutical Ingredients Market by Synthetic, 2022 – 2030 (USD Billion)
  • 11. Global Active Pharmaceutical Ingredients Market by Biotech, 2022 – 2030 (USD Billion)
  • 12. Global Active Pharmaceutical Ingredients Market share by Manufacturer, 2022 and 2030 (USD Billion)
  • 13. Global Active Pharmaceutical Ingredients Market by Merchant, 2022 – 2030 (USD Billion)
  • 14. Global Active Pharmaceutical Ingredients Market by Captive, 2022 – 2030 (USD Billion)
  • 15. Global Active Pharmaceutical Ingredients Market share by Type, 2022 and 2030 (USD Billion)
  • 16. Global Active Pharmaceutical Ingredients Market by Innovative, 2022 – 2030 (USD Billion)
  • 17. Global Active Pharmaceutical Ingredients Market by Generic, 2022 – 2030 (USD Billion)
  • 18. Global Active Pharmaceutical Ingredients Market share by Application, 2022 and 2030 (USD Billion)
  • 19. Global Active Pharmaceutical Ingredients Market by Oncology, 2022 – 2030 (USD Billion)
  • 20. Global Active Pharmaceutical Ingredients Market by Cardiovascular diseases, 2022 – 2030 (USD Billion)
  • 21. Global Active Pharmaceutical Ingredients Market by Ophthalmology, 2022 – 2030 (USD Billion)
  • 22. Global Active Pharmaceutical Ingredients Market by Orthopedic, 2022 – 2030 (USD Billion)
  • 23. Global Active Pharmaceutical Ingredients Market by Central nervous system, 2022 – 2030 (USD Billion)
  • 24. Global Active Pharmaceutical Ingredients Market by neurology, 2022 – 2030 (USD Billion)
  • 25. Global Active Pharmaceutical Ingredients Market by Gastro enterology, 2022 – 2030 (USD Billion)
  • 26. Global Active Pharmaceutical Ingredients Market by Nephrology, 2022 – 2030 (USD Billion)
  • 27. Global Active Pharmaceutical Ingredients Market share, by Region, 2022 and 2030
  • 28. North America Active Pharmaceutical Ingredients Market, 2022 – 2030 (USD Billion)
  • 29. Europe Active Pharmaceutical Ingredients Market, 2022 – 2030 (USD Billion)
  • 30. Asia Pacific Active Pharmaceutical Ingredients Market, 2022 – 2030 (USD Billion)
  • 31. Latin America Active Pharmaceutical Ingredients Market, 2022 – 2030 (USD Billion)
  • 32. The Middle-East and Africa Active Pharmaceutical Ingredients Market, 2022 – 2030 (USD Billion)

List Of Tables

  • 1. Global Active Pharmaceutical Ingredients Market: Snapshot
  • 2. Drivers of the Active Pharmaceutical Ingredients Market: impact analysis
  • 3. North America Active Pharmaceutical Ingredients Market revenue, By Synthesis, 2022 – 2030 (USD Billion)
  • 4. North America Active Pharmaceutical Ingredients Market revenue, By Manufacturer, 2022 – 2030 (USD Billion)
  • 5. North America Active Pharmaceutical Ingredients Market revenue, By Type, 2022 – 2030 (USD Billion)
  • 6. North America Active Pharmaceutical Ingredients Market revenue, By Application, 2022 – 2030 (USD Billion)
  • 7. U.S. Active Pharmaceutical Ingredients Market revenue, By Synthesis, 2022 – 2030 (USD Billion)
  • 8. U.S. Active Pharmaceutical Ingredients Market revenue, By Manufacturer, 2022 – 2030 (USD Billion)
  • 9. U.S. Active Pharmaceutical Ingredients Market revenue, By Type, 2022 – 2030 (USD Billion)
  • 10. U.S. Active Pharmaceutical Ingredients Market revenue, By Application, 2022 – 2030 (USD Billion)
  • 11. Canada Active Pharmaceutical Ingredients Market revenue, By Synthesis, 2022 – 2030 (USD Billion)
  • 12. Canada Active Pharmaceutical Ingredients Market revenue, By Manufacturer, 2022 – 2030 (USD Billion)
  • 13. Canada Active Pharmaceutical Ingredients Market revenue, By Type, 2022 – 2030 (USD Billion)
  • 14. Canada Active Pharmaceutical Ingredients Market revenue, By Application, 2022 – 2030 (USD Billion)
  • 15. Europe Active Pharmaceutical Ingredients Market revenue, By Synthesis, 2022 – 2030 (USD Billion)
  • 16. Europe Active Pharmaceutical Ingredients Market revenue, By Manufacturer, 2022 – 2030 (USD Billion)
  • 17. Europe Active Pharmaceutical Ingredients Market revenue, By Type, 2022 – 2030 (USD Billion)
  • 18. Europe Active Pharmaceutical Ingredients Market revenue, By Application, 2022 – 2030 (USD Billion)
  • 19. Germany Active Pharmaceutical Ingredients Market revenue, By Synthesis, 2022 – 2030 (USD Billion)
  • 20. Germany Active Pharmaceutical Ingredients Market revenue, By Manufacturer, 2022 – 2030 (USD Billion)
  • 21. Germany Active Pharmaceutical Ingredients Market revenue, By Type, 2022 – 2030 (USD Billion)
  • 22. Germany Active Pharmaceutical Ingredients Market revenue, By Application, 2022 – 2030 (USD Billion)
  • 23. France Active Pharmaceutical Ingredients Market revenue, By Synthesis, 2022 – 2030 (USD Billion)
  • 24. France Active Pharmaceutical Ingredients Market revenue, By Manufacturer, 2022 – 2030 (USD Billion)
  • 25. France Active Pharmaceutical Ingredients Market revenue, By Type, 2022 – 2030 (USD Billion)
  • 26. France Active Pharmaceutical Ingredients Market revenue, By Application, 2022 – 2030 (USD Billion)
  • 27. U.K. Active Pharmaceutical Ingredients Market revenue, By Synthesis, 2022 – 2030 (USD Billion)
  • 28. U.K. Active Pharmaceutical Ingredients Market revenue, By Manufacturer, 2022 – 2030 (USD Billion)
  • 29. U.K. Active Pharmaceutical Ingredients Market revenue, By Type, 2022 – 2030 (USD Billion)
  • 30. U.K. Active Pharmaceutical Ingredients Market revenue, By Application, 2022 – 2030 (USD Billion)
  • 31. Italy Active Pharmaceutical Ingredients Market revenue, By Synthesis, 2022 – 2030 (USD Billion)
  • 32. Italy Active Pharmaceutical Ingredients Market revenue, By Manufacturer, 2022 – 2030 (USD Billion)
  • 33. Italy Active Pharmaceutical Ingredients Market revenue, By Type, 2022 – 2030 (USD Billion)
  • 34. Italy Active Pharmaceutical Ingredients Market revenue, By Application, 2022 – 2030 (USD Billion)
  • 35. Spain Active Pharmaceutical Ingredients Market revenue, By Synthesis, 2022 – 2030 (USD Billion)
  • 36. Spain Active Pharmaceutical Ingredients Market revenue, By Manufacturer, 2022 – 2030 (USD Billion)
  • 37. Spain Active Pharmaceutical Ingredients Market revenue, By Type, 2022 – 2030 (USD Billion)
  • 38. Spain Active Pharmaceutical Ingredients Market revenue, By Application, 2022 – 2030 (USD Billion)
  • 39. Rest of Europe Active Pharmaceutical Ingredients Market revenue, By Synthesis, 2022 – 2030 (USD Billion)
  • 40. Rest of Europe Active Pharmaceutical Ingredients Market revenue, By Manufacturer, 2022 – 2030 (USD Billion)
  • 41. Rest of Europe Active Pharmaceutical Ingredients Market revenue, By Type, 2022 – 2030 (USD Billion)
  • 42. Rest of Europe Active Pharmaceutical Ingredients Market revenue, By Application, 2022 – 2030 (USD Billion)
  • 43. Asia Pacific Active Pharmaceutical Ingredients Market revenue, By Synthesis, 2022 – 2030 (USD Billion)
  • 44. Asia Pacific Active Pharmaceutical Ingredients Market revenue, By Manufacturer, 2022 – 2030 (USD Billion)
  • 45. Asia Pacific Active Pharmaceutical Ingredients Market revenue, By Type, 2022 – 2030 (USD Billion)
  • 46. Asia Pacific Active Pharmaceutical Ingredients Market revenue, By Application, 2022 – 2030 (USD Billion)
  • 47. China Active Pharmaceutical Ingredients Market revenue, By Synthesis, 2022 – 2030 (USD Billion)
  • 48. China Active Pharmaceutical Ingredients Market revenue, By Manufacturer, 2022 – 2030 (USD Billion)
  • 49. China Active Pharmaceutical Ingredients Market revenue, By Type, 2022 – 2030 (USD Billion)
  • 50. China Active Pharmaceutical Ingredients Market revenue, By Application, 2022 – 2030 (USD Billion)
  • 51. Japan Active Pharmaceutical Ingredients Market revenue, By Synthesis, 2022 – 2030 (USD Billion)
  • 52. Japan Active Pharmaceutical Ingredients Market revenue, By Manufacturer, 2022 – 2030 (USD Billion)
  • 53. Japan Active Pharmaceutical Ingredients Market revenue, By Type, 2022 – 2030 (USD Billion)
  • 54. Japan Active Pharmaceutical Ingredients Market revenue, By Application, 2022 – 2030 (USD Billion)
  • 55. India Active Pharmaceutical Ingredients Market revenue, By Synthesis, 2022 – 2030 (USD Billion)
  • 56. India Active Pharmaceutical Ingredients Market revenue, By Manufacturer, 2022 – 2030 (USD Billion)
  • 57. India Active Pharmaceutical Ingredients Market revenue, By Type, 2022 – 2030 (USD Billion)
  • 58. India Active Pharmaceutical Ingredients Market revenue, By Application, 2022 – 2030 (USD Billion)
  • 59. South Korea Active Pharmaceutical Ingredients Market revenue, By Synthesis, 2022 – 2030 (USD Billion)
  • 60. South Korea Active Pharmaceutical Ingredients Market revenue, By Manufacturer, 2022 – 2030 (USD Billion)
  • 61. South Korea Active Pharmaceutical Ingredients Market revenue, By Type, 2022 – 2030 (USD Billion)
  • 62. South Korea Active Pharmaceutical Ingredients Market revenue, By Application, 2022 – 2030 (USD Billion)
  • 63. South-East Asia Active Pharmaceutical Ingredients Market revenue, By Synthesis, 2022 – 2030 (USD Billion)
  • 64. South-East Asia Active Pharmaceutical Ingredients Market revenue, By Manufacturer, 2022 – 2030 (USD Billion)
  • 65. South-East Asia Active Pharmaceutical Ingredients Market revenue, By Type, 2022 – 2030 (USD Billion)
  • 66. South-East Asia Active Pharmaceutical Ingredients Market revenue, By Application, 2022 – 2030 (USD Billion)
  • 67. Rest of Asia Pacific Active Pharmaceutical Ingredients Market revenue, By Synthesis, 2022 – 2030 (USD Billion)
  • 68. Rest of Asia Pacific Active Pharmaceutical Ingredients Market revenue, By Manufacturer, 2022 – 2030 (USD Billion)
  • 69. Rest of Asia Pacific Active Pharmaceutical Ingredients Market revenue, By Type, 2022 – 2030 (USD Billion)
  • 70. Rest of Asia Pacific Active Pharmaceutical Ingredients Market revenue, By Application, 2022 – 2030 (USD Billion)
  • 71. Latin America Active Pharmaceutical Ingredients Market revenue, By Synthesis, 2022 – 2030 (USD Billion)
  • 72. Latin America Active Pharmaceutical Ingredients Market revenue, By Manufacturer, 2022 – 2030 (USD Billion)
  • 73. Latin America Active Pharmaceutical Ingredients Market revenue, By Type, 2022 – 2030 (USD Billion)
  • 74. Latin America Active Pharmaceutical Ingredients Market revenue, By Application, 2022 – 2030 (USD Billion)
  • 75. Brazil Active Pharmaceutical Ingredients Market revenue, By Synthesis, 2022 – 2030 (USD Billion)
  • 76. Brazil Active Pharmaceutical Ingredients Market revenue, By Manufacturer, 2022 – 2030 (USD Billion)
  • 77. Brazil Active Pharmaceutical Ingredients Market revenue, By Type, 2022 – 2030 (USD Billion)
  • 78. Brazil Active Pharmaceutical Ingredients Market revenue, By Application, 2022 – 2030 (USD Billion)
  • 79. Mexico Active Pharmaceutical Ingredients Market revenue, By Synthesis, 2022 – 2030 (USD Billion)
  • 80. Mexico Active Pharmaceutical Ingredients Market revenue, By Manufacturer, 2022 – 2030 (USD Billion)
  • 81. Mexico Active Pharmaceutical Ingredients Market revenue, By Type, 2022 – 2030 (USD Billion)
  • 82. Mexico Active Pharmaceutical Ingredients Market revenue, By Application, 2022 – 2030 (USD Billion)
  • 83. Rest of Latin America Active Pharmaceutical Ingredients Market revenue, By Synthesis, 2022 – 2030 (USD Billion)
  • 84. Rest of Latin America Active Pharmaceutical Ingredients Market revenue, By Manufacturer, 2022 – 2030 (USD Billion)
  • 85. Rest of Latin America Active Pharmaceutical Ingredients Market revenue, By Type, 2022 – 2030 (USD Billion)
  • 86. Rest of Latin America Active Pharmaceutical Ingredients Market revenue, By Application, 2022 – 2030 (USD Billion)
  • 87. The Middle-East and Africa Active Pharmaceutical Ingredients Market revenue, By Synthesis, 2022 – 2030 (USD Billion)
  • 88. The Middle-East and Africa Active Pharmaceutical Ingredients Market revenue, By Manufacturer, 2022 – 2030 (USD Billion)
  • 89. The Middle-East and Africa Active Pharmaceutical Ingredients Market revenue, By Type, 2022 – 2030 (USD Billion)
  • 90. The Middle-East and Africa Active Pharmaceutical Ingredients Market revenue, By Application, 2022 – 2030 (USD Billion)
  • 91. GCC Countries Active Pharmaceutical Ingredients Market revenue, By Synthesis, 2022 – 2030 (USD Billion)
  • 92. GCC Countries Active Pharmaceutical Ingredients Market revenue, By Manufacturer, 2022 – 2030 (USD Billion)
  • 93. GCC Countries Active Pharmaceutical Ingredients Market revenue, By Type, 2022 – 2030 (USD Billion)
  • 94. GCC Countries Active Pharmaceutical Ingredients Market revenue, By Application, 2022 – 2030 (USD Billion)
  • 95. South Africa Active Pharmaceutical Ingredients Market revenue, By Synthesis, 2022 – 2030 (USD Billion)
  • 96. South Africa Active Pharmaceutical Ingredients Market revenue, By Manufacturer, 2022 – 2030 (USD Billion)
  • 97. South Africa Active Pharmaceutical Ingredients Market revenue, By Type, 2022 – 2030 (USD Billion)
  • 98. South Africa Active Pharmaceutical Ingredients Market revenue, By Application, 2022 – 2030 (USD Billion)
  • 99. Rest of Middle-East Africa Active Pharmaceutical Ingredients Market revenue, By Synthesis, 2022 – 2030 (USD Billion)
  • 100. Rest of Middle-East Africa Active Pharmaceutical Ingredients Market revenue, By Manufacturer, 2022 – 2030 (USD Billion)
  • 101. Rest of Middle-East Africa Active Pharmaceutical Ingredients Market revenue, By Type, 2022 – 2030 (USD Billion)
  • 102. Rest of Middle-East Africa Active Pharmaceutical Ingredients Market revenue, By Application, 2022 – 2030 (USD Billion)

Report Methodology

In order to get the most precise estimates and forecasts possible, Custom Market Insights applies a detailed and adaptive research methodology centered on reducing deviations. For segregating and assessing quantitative aspects of the market, the company uses a combination of top-down and bottom-up approaches. Furthermore, data triangulation, which examines the market from three different aspects, is a recurring theme in all of our research reports. The following are critical components of the methodology used in all of our studies:

Preliminary Data Mining

On a broad scale, raw market information is retrieved and compiled. Data is constantly screened to make sure that only substantiated and verified sources are taken into account. Furthermore, data is mined from a plethora of reports in our archive and also a number of reputed & reliable paid databases. To gain a detailed understanding of the business, it is necessary to know the entire product life cycle and to facilitate this, we gather data from different suppliers, distributors, and buyers.

Surveys, technological conferences, and trade magazines are used to identify technical issues and trends. Technical data is also gathered from the standpoint of intellectual property, with a focus on freedom of movement and white space. The dynamics of the industry in terms of drivers, restraints, and valuation trends are also gathered. As a result, the content created contains a diverse range of original data, which is then cross-validated and verified with published sources.

Statistical Model

Simulation models are used to generate our business estimates and forecasts. For each study, a one-of-a-kind model is created. Data gathered for market dynamics, the digital landscape, development services, and valuation patterns are fed into the prototype and analyzed concurrently. These factors are compared, and their effect over the projected timeline is quantified using correlation, regression, and statistical modeling. Market forecasting is accomplished through the use of a combination of economic techniques, technical analysis, industry experience, and domain knowledge.

Short-term forecasting is typically done with econometric models, while long-term forecasting is done with technological market models. These are based on a synthesis of the technological environment, legal frameworks, economic outlook, and business regulations. Bottom-up market evaluation is favored, with crucial regional markets reviewed as distinct entities and data integration to acquire worldwide estimates. This is essential for gaining a thorough knowledge of the industry and ensuring that errors are kept to a minimum.

Some of the variables taken into account for forecasting are as follows:

• Industry drivers and constraints, as well as their current and projected impact

• The raw material case, as well as supply-versus-price trends

• Current volume and projected volume growth through 2030

We allocate weights to these variables and use weighted average analysis to determine the estimated market growth rate.

Primary Validation

This is the final step in our report’s estimating and forecasting process. Extensive primary interviews are carried out, both in-person and over the phone, to validate our findings and the assumptions that led to them.
Leading companies from across the supply chain, including suppliers, technology companies, subject matter experts, and buyers, use techniques like interviewing to ensure a comprehensive and non-biased overview of the business. These interviews are conducted all over the world, with the help of local staff and translators, to overcome language barriers.

Primary interviews not only aid with data validation, but also offer additional important insight into the industry, existing business scenario, and future projections, thereby improving the quality of our reports.

All of our estimates and forecasts are validated through extensive research work with key industry participants (KIPs), which typically include:

• Market leaders

• Suppliers of raw materials

• Suppliers of raw materials

• Buyers.

The following are the primary research objectives:

• To ensure the accuracy and acceptability of our data.

• Gaining an understanding of the current market and future projections.

Data Collection Matrix

Perspective Primary research Secondary research
Supply-side
  • Manufacturers
  • Technology distributors and wholesalers
  • Company reports and publications
  • Government publications
  • Independent investigations
  • Economic and demographic data
Demand-side
  • End-user surveys
  • Consumer surveys
  • Mystery shopping
  • Case studies
  • Reference customers


Market Analysis Matrix

Qualitative analysis Quantitative analysis
  • Industry landscape and trends
  • Market dynamics and key issues
  • Technology landscape
  • Market opportunities
  • Porter’s analysis and PESTEL analysis
  • Competitive landscape and component benchmarking
  • Policy and regulatory scenario
  • Market revenue estimates and forecast up to 2028
  • Market revenue estimates and forecasts up to 2028, by technology
  • Market revenue estimates and forecasts up to 2028, by application
  • Market revenue estimates and forecasts up to 2028, by type
  • Market revenue estimates and forecasts up to 2028, by component
  • Regional market revenue forecasts, by technology
  • Regional market revenue forecasts, by application
  • Regional market revenue forecasts, by type
  • Regional market revenue forecasts, by component

Key Players

  • Merck & Co Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Albemarle Corporation
  • Viatris Inc.
  • Aurobindo Pharma
  • Sun Pharmaceutical Industries Ltd.
  • AbbVie Inc.
  • Bristol-Myers Squibb Company
  • Boehringer Ingelheim International GmbH
  • Cipla Inc.
  • Reddy’s Laboratories Ltd.

FAQs

“North American” region will lead the global Active Pharmaceutical Ingredients market during the forecast period 2022 to 2030.

The key factors driving the market are Increasing Geriatric Population, Sedentary Lifestyle, Chronic Disorders

.

The key players operating in the Active Pharmaceutical Ingredients market are Merck & Co Inc., Teva Pharmaceutical Industries Ltd., Albemarle Corporation, Viatris Inc., Aurobindo Pharma, Sun Pharmaceutical Industries Ltd., AbbVie Inc., Bristol-Myers Squibb Company, Boehringer Ingelheim International GmbH, Cipla Inc., Dr. Reddy’s Laboratories Ltd.

The global Active Pharmaceutical Ingredients market is expanding growth with a CAGR of approximately 6.80% during the forecast period (2022 to 2030).

The global Active Pharmaceutical Ingredients market size was valued at USD 174.18 billion in 2021 and it is projected to reach around USD 355.87 billion by 2030.

PURCHASE OPTIONS

excel
$

3200


pdf excel
$

4200


pdf excel powerbi
$

5200


excel
$

1800


pdf excel powerbi
pdf
$

6200

What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • Free 25% or 40 hours of customisation.
  • Free post-sale service assistance.
  • 15% discount on your next purchase.
  • Dedicated account Associate .
  • Permission to print the report.
  • Service guarantee available.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • Free 35% or 60 hours of customisation.
  • Free post-sale service assistance.
  • 25% discount on your next purchase.
  • Service guarantee available.
  • Personalised market brief by author.
  • Permission to print the report.
  • PDF, Excel and Power Point.
  • Can be accessible by unlimited users.
  • Free 40% or 80 hours of customisation.
  • Free post-sale service assistance.
  • 30% discount on your next purchase.
  • Permission to print the report.
  • Dedicated account manager.
  • Service guarantee available.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.
  • 15% discount on your next purchase.
  • Free 20% or 10 hours of customisation.
  • PDF, Excel, Power Point and Power BI.
  • Every Year Free Update ( Apr – Apr)
  • Personalized market brief by author
  • Can be accessible by unlimited users.
  • Free 50% or 90 hours of customization.
  • Up to 50 Company Profiles
  • Free post-sale service assistance with guarantee
  • 40% discount on your next purchase.
  • Permission to print the report.
  • Dedicated account team.
  • Service guarantee available.
View cart

Want to customize this report?
100% FREE CUSTOMIZATION!